• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIATORR® TIPS ENDOPROSTHESIS; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIATORR® TIPS ENDOPROSTHESIS; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS Back to Search Results
Catalog Number PTB8108275
Device Problem Complete Blockage (1094)
Patient Problem Thrombosis (2100)
Event Date 04/03/2018
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records for the device verified that the lot met all pre-release specifications.The device remains implanted so no engineering investigation could be performed.(b)(4).
 
Event Description
It was reported that the physician was implanting a gore® viatorr® tips endoprosthesis with controlled expansion for a transjugular intrahepatic portosystemic shunt (tips) procedure.The patient presented with non occlusive portal vein thrombosis prior to tips implantation.The device was deployed to 8mm.According to the physician, the device appeared to completely cover the hepatic vein to the inferior vena cava on ct.The device was deployed and implanted without incident.The physician brought the patient in for a one-week follow up.The physician did not see any flow through the device under ultrasound and thought it may just be due to the wet-out of the ptfe device.The patient was brought back in due to worsened ascites and to re-do the ultrasound one week later (two weeks post implant) and the physician could still not see any flow through the device under ultrasound.Thrombosis of the device was suspected.The physician performed a venogram to determine the patency of the device.The venogram showed that the stent and portal vein had thrombosed and also showed thrombus in the smv.The physician is planning for the patient to get lysed overnight.After the patient was lysed, the patient came back for thrombectomy (angio jet, boston scientific).The physician dilated the viatorr cx stent and relined half of the viatorr cx with a covered stent and extended into the ivc.The physician lined the portal vein with a bare metal stent.The physician reports that the patient did very well.The patient was put on anticoagulants for 6 months.The physician stated that he can't say for sure that the thrombus was due to the device because there was preexisting portal vein thrombosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIATORR® TIPS ENDOPROSTHESIS
Type of Device
SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
ashley marostica
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7506371
MDR Text Key107985860
Report Number3007284313-2018-00149
Device Sequence Number1
Product Code MIR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/02/2021
Device Catalogue NumberPTB8108275
Device Lot Number17738999
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/03/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age62 YR
-
-